$0.8500
-0.02-2.30%
At close: -
$0.8304
-0.02-2.31%
After Hours: Jan 24, 6:13 PM EDT
Comments
Loading...
Bio-Path Hldgs (BPTH) Forecast
NewsEarningsBio-Path Hldgs (BPTH) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestBio-Path Hldgs (NASDAQ:BPTH) Stock Quotes, Forecast and News Summary
Bio-Path Hldgs Stock (NASDAQ: BPTH) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Bio-Path Hldgs (BPTH) stock?
You can purchase shares of Bio-Path Hldgs (NASDAQ:BPTH) through any online brokerage.
Who are Bio-Path Hldgs (BPTH) competitors?
Other companies in Bio-Path Hldgs’s space includes: Vincerx Pharma (NASDAQ:VINC), Syros Pharmaceuticals (NASDAQ:SYRS), Tharimmune (NASDAQ:THAR), Synaptogenix (NASDAQ:SNPX) and Cyclacel Pharmaceuticals (NASDAQ:CYCC).
What is the forecast, or price target, for Bio-Path Hldgs (BPTH) stock?
Bio-Path Hldgs has a consensus price target of $23.00.
What is the current price for Bio-Path Hldgs (BPTH)?
The stock price for Bio-Path Hldgs (NASDAQ: BPTH) is $0.8304 last updated January 24, 2025 at 6:13 PM EST.
Does Bio-Path Hldgs (BPTH) pay a dividend?
There are no upcoming dividends for Bio-Path Hldgs.
When is Bio-Path Hldgs (NASDAQ:BPTH) reporting earnings?
Bio-Path Hldgs’s Q4 earnings are confirmed for Friday, March 7, 2025.
Is Bio-Path Hldgs (BPTH) going to split?
There is no upcoming split for Bio-Path Hldgs.
What sector and industry does Bio-Path Hldgs (BPTH) operate in?
Bio-Path Hldgs is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.